Rigel Pharmaceuticals (RIGL) Gross Margin Growth (3y) (2021 - 2026)
Rigel Pharmaceuticals (RIGL) Gross Margin Growth (3y) (2021 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Gross Margin Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
7,249.00 |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
-191.00 |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Rigel Pharmaceuticals |
603.18 Mn |
456.49 Mn |
54.21 Mn |
-408.00 |
| Date | Value |
|---|
| Mar 31, 2026 |
-408.00 |
| Dec 31, 2025 |
-786.00 |
| Sep 30, 2025 |
-573.00 |
| Jun 30, 2025 |
-96.00 |
| Mar 31, 2025 |
-754.00 |
| Dec 31, 2024 |
-766.00 |
| Sep 30, 2024 |
-1,381.00 |
| Jun 30, 2024 |
-713.00 |
| Mar 31, 2024 |
-647.00 |
| Dec 31, 2023 |
-885.00 |
| Sep 30, 2023 |
-375.00 |
| Jun 30, 2023 |
-226.00 |
| Mar 31, 2023 |
-347.00 |
| Dec 31, 2022 |
49.00 |
| Sep 30, 2022 |
37.00 |
| Jun 30, 2022 |
-49.00 |
| Mar 31, 2022 |
12.00 |
| Dec 31, 2021 |
-189.00 |
| Sep 30, 2021 |
72.00 |
| Jun 30, 2021 |
119.00 |
